$TELESIS BIO(TBIO.US)$ NEWS Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership Telesis Bio focuses on Gibson SOLA and BioXp platforms for DNA and mRNA synthesis Collaborations aim to accelerate drug discovery with rapid vaccine and therapeutic candidate identification Operational restructuring leads to significant cost savings and extends cash runway
⭕上市公司的早期投资者在IPO锁定期结束后是否有减持,其在不同股价区间有多大程度的增持或减持,往往可以看作对公司有深度了解的知情者对公司前景的投票结果。 …in an IPO, there is a lock-up period—typically between 90 to 180 days—in which shareholders are restricted from selling outside of the Initial Public Offering. ⭕$TELESIS BIO(TBIO.US)$的早期风投,内部人士以及战略投资者$丹纳赫(DHR.US)$的持仓变化似乎就可以说明一些问题。 ⭕对公司护城河以及护城河构建者的了解往往又可从另一个角度对公司前景有所预判。比如,$TELESIS BIO(TBIO.US)$首席技术官 Dan Gibson 5年前的一个TED演讲,是否能增加你对公司的认知呢?——How to build synthetic DNA and send it across the internet ⭕对不同时...
TELESIS BIO股票讨论区
NEWS
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
Telesis Bio focuses on Gibson SOLA and BioXp platforms for DNA and mRNA synthesis
Collaborations aim to accelerate drug discovery with rapid vaccine and therapeutic candidate identification
Operational restructuring leads to significant cost savings and extends cash runway
…in an IPO, there is a lock-up period—typically between 90 to 180 days—in which shareholders are restricted from selling outside of the Initial Public Offering.
⭕ $TELESIS BIO(TBIO.US)$ 的早期风投,内部人士以及战略投资者 $丹纳赫(DHR.US)$ 的持仓变化似乎就可以说明一些问题。
⭕对公司护城河以及护城河构建者的了解往往又可从另一个角度对公司前景有所预判。比如, $TELESIS BIO(TBIO.US)$ 首席技术官 Dan Gibson 5年前的一个TED演讲,是否能增加你对公司的认知呢?——How to build synthetic DNA and send it across the internet
⭕对不同时...
暂无评论